South Korea Home Infusion Therapy Market Size, Share, Trends and Forecast by Product, Application, and Region, 2026-2034
The South Korea home infusion therapy market size reached USD 908.9 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 1,410.0 Million by 2034, exhibiting a growth rate (CAGR) of 4.85% during 2026-2034. The home infusion therapy in South Korea is growing owing to an aging population, rising demand for in-home care, strong digital infrastructure, and expanding use of remote monitoring tools. Improved care coordination, policy support, and accessible smart devices are making home-based treatment safer and more widely adopted, thereby increasing the South Korea home infusion therapy market share.
SOUTH KOREA HOME INFUSION THERAPY MARKET TRENDS:
Aging Population and Shift in Care Preferences
The rising geriatric population, who is easily susceptible to chronic conditions, is propelling the market growth. As per the 2024 Statistics on the Aged, people aged 65 and above currently make up 19.2% of the population, and forecasts suggest this will exceed 20% in 2025 and reach 30% by 2036. With an increasing number of seniors needing continuous care, many opt for home treatment instead of hospital stays, which can be both costly and emotionally draining. Home infusion therapy enables the delivery of treatments, such as IV antibiotics, nutrition, and pain management, in a comfortable environment, lessening the strain on families and preventing frequent hospital trips. Hospitals also benefit, as shifting eligible patients to home care helps reduce bed shortages and readmission rates. This is encouraging both public and private healthcare sectors to invest in at-home services, with government programs starting to promote wider access and execution.
Technological Readiness and Service Infrastructure
The sophisticated digital ecosystem plays a crucial role in impelling the South Korea home infusion therapy market growth. In 2024, the eHealth market in the country achieved USD 2.7 billion, indicating extensive usage of mobile health applications, teleconsultation services, remote monitoring solutions, and electronic records. These technologies facilitate communication among hospitals, pharmacies, patients, and homecare providers, allowing them to manage treatment schedules without in-person visits. Monitoring vitals and infusion progress remotely enables providers to react swiftly to any problems, while logistics systems guarantee timely arrival of medications and supplies. Home-use devices are becoming more user-friendly, enabling patients and caregivers to manage therapy with minimal clinical assistance. Regulatory agencies are starting to modify policy structures to promote home-based approaches, especially for managing chronic diseases. The integration of digital preparedness and policy coordination is making home infusion therapy a viable, reliable choice for an increasing number of patients nationwide.
Growing Use of Remote Monitoring and Smart Devices
In South Korea, wearable devices and remote monitoring tools are enhancing the reliability and clinical management of home infusion therapy. In 2025, Seers Technology released MobiCare, a wearable ECG gadget that allows for AI-driven, instant monitoring of arrhythmia and various conditions. Together with Think , its hospital monitoring system, these tools provide 24/7 supervision without the need for constant physical presence. Such systems enable healthcare professionals to monitor vitals, infusion rates, and warning indicators remotely, facilitating quicker responses in case complications occur. Patients and families gain reassurance, understanding that care teams are digitally linked and can intervene when required. The incorporation of these tools with electronic health records (EHRs) improves the continuity of care between home and hospital. With these technologies becoming easily available via subscription models, operational costs for facilities are decreasing, making home infusion a more viable option for patients with complex or high-risk conditions.
SOUTH KOREA HOME INFUSION THERAPY MARKET SEGMENTATION:
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country and regional levels for 2026-2034. Our report has categorized the market based on product and application.
Product Insights:
Application Insights:
Regional Insights:
COMPETITIVE LANDSCAPE:
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
KEY QUESTIONS ANSWERED IN THIS REPORT
How has the South Korea home infusion therapy market performed so far and how will it perform in the coming years?
What is the breakup of the South Korea home infusion therapy market on the basis of product?
What is the breakup of the South Korea home infusion therapy market on the basis of application?
What is the breakup of the South Korea home infusion therapy market on the basis of region?
What are the various stages in the value chain of the South Korea home infusion therapy market?
What are the key driving factors and challenges in the South Korea home infusion therapy market?
What is the structure of the South Korea home infusion therapy market and who are the key players?
What is the degree of competition in the South Korea home infusion therapy market?
SOUTH KOREA HOME INFUSION THERAPY MARKET TRENDS:
Aging Population and Shift in Care Preferences
The rising geriatric population, who is easily susceptible to chronic conditions, is propelling the market growth. As per the 2024 Statistics on the Aged, people aged 65 and above currently make up 19.2% of the population, and forecasts suggest this will exceed 20% in 2025 and reach 30% by 2036. With an increasing number of seniors needing continuous care, many opt for home treatment instead of hospital stays, which can be both costly and emotionally draining. Home infusion therapy enables the delivery of treatments, such as IV antibiotics, nutrition, and pain management, in a comfortable environment, lessening the strain on families and preventing frequent hospital trips. Hospitals also benefit, as shifting eligible patients to home care helps reduce bed shortages and readmission rates. This is encouraging both public and private healthcare sectors to invest in at-home services, with government programs starting to promote wider access and execution.
Technological Readiness and Service Infrastructure
The sophisticated digital ecosystem plays a crucial role in impelling the South Korea home infusion therapy market growth. In 2024, the eHealth market in the country achieved USD 2.7 billion, indicating extensive usage of mobile health applications, teleconsultation services, remote monitoring solutions, and electronic records. These technologies facilitate communication among hospitals, pharmacies, patients, and homecare providers, allowing them to manage treatment schedules without in-person visits. Monitoring vitals and infusion progress remotely enables providers to react swiftly to any problems, while logistics systems guarantee timely arrival of medications and supplies. Home-use devices are becoming more user-friendly, enabling patients and caregivers to manage therapy with minimal clinical assistance. Regulatory agencies are starting to modify policy structures to promote home-based approaches, especially for managing chronic diseases. The integration of digital preparedness and policy coordination is making home infusion therapy a viable, reliable choice for an increasing number of patients nationwide.
Growing Use of Remote Monitoring and Smart Devices
In South Korea, wearable devices and remote monitoring tools are enhancing the reliability and clinical management of home infusion therapy. In 2025, Seers Technology released MobiCare, a wearable ECG gadget that allows for AI-driven, instant monitoring of arrhythmia and various conditions. Together with Think , its hospital monitoring system, these tools provide 24/7 supervision without the need for constant physical presence. Such systems enable healthcare professionals to monitor vitals, infusion rates, and warning indicators remotely, facilitating quicker responses in case complications occur. Patients and families gain reassurance, understanding that care teams are digitally linked and can intervene when required. The incorporation of these tools with electronic health records (EHRs) improves the continuity of care between home and hospital. With these technologies becoming easily available via subscription models, operational costs for facilities are decreasing, making home infusion a more viable option for patients with complex or high-risk conditions.
SOUTH KOREA HOME INFUSION THERAPY MARKET SEGMENTATION:
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country and regional levels for 2026-2034. Our report has categorized the market based on product and application.
Product Insights:
- Infusion Pumps
- Elastomeric
- Electromechanical
- Gravity
- Others
- Intravenous Sets
- IV Cannulas
- Needleless Connectors
Application Insights:
- Anti-Infective
- Endocrinology
- Diabetes
- Others
- Hydration Therapy
- Athletes
- Others
- Chemotherapy
- Enteral Nutrition
- Parenteral Nutrition
- Specialty Pharmaceuticals
Regional Insights:
- Seoul Capital Area
- Yeongnam (Southeastern Region)
- Honam (Southwestern Region)
- Hoseo (Central Region)
COMPETITIVE LANDSCAPE:
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
KEY QUESTIONS ANSWERED IN THIS REPORT
How has the South Korea home infusion therapy market performed so far and how will it perform in the coming years?
What is the breakup of the South Korea home infusion therapy market on the basis of product?
What is the breakup of the South Korea home infusion therapy market on the basis of application?
What is the breakup of the South Korea home infusion therapy market on the basis of region?
What are the various stages in the value chain of the South Korea home infusion therapy market?
What are the key driving factors and challenges in the South Korea home infusion therapy market?
What is the structure of the South Korea home infusion therapy market and who are the key players?
What is the degree of competition in the South Korea home infusion therapy market?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 SOUTH KOREA HOME INFUSION THERAPY MARKET - INTRODUCTION
4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence
5 SOUTH KOREA HOME INFUSION THERAPY MARKET LANDSCAPE
5.1 Historical and Current Market Trends (2020-2025)
5.2 Market Forecast (2026-2034)
6 SOUTH KOREA HOME INFUSION THERAPY MARKET - BREAKUP BY PRODUCT
6.1 Infusion Pumps
6.1.1 Overview
6.1.2 Historical and Current Market Trends (2020-2025)
6.1.3 Market Segmentation
6.1.3.1 Elastomeric
6.1.3.2 Electromechanical
6.1.3.3 Gravity
6.1.3.4 Others
6.1.4 Market Forecast (2026-2034)
6.2 Intravenous Sets
6.2.1 Overview
6.2.2 Historical and Current Market Trends (2020-2025)
6.2.3 Market Forecast (2026-2034)
6.3 IV Cannulas
6.3.1 Overview
6.3.2 Historical and Current Market Trends (2020-2025)
6.3.3 Market Forecast (2026-2034)
6.4 Needleless Connectors
6.4.1 Overview
6.4.2 Historical and Current Market Trends (2020-2025)
6.4.3 Market Forecast (2026-2034)
7 SOUTH KOREA HOME INFUSION THERAPY MARKET - BREAKUP BY APPLICATION
7.1 Anti-Infective
7.1.1 Overview
7.1.2 Historical and Current Market Trends (2020-2025)
7.1.3 Market Forecast (2026-2034)
7.2 Endocrinology
7.2.1 Overview
7.2.2 Historical and Current Market Trends (2020-2025)
7.2.3 Market Segmentation
7.2.3.1 Diabetes
7.2.3.2 Others
7.2.4 Market Forecast (2026-2034)
7.3 Hydration Therapy
7.3.1 Overview
7.3.2 Historical and Current Market Trends (2020-2025)
7.3.3 Market Segmentation
7.3.3.1 Athletes
7.3.3.2 Others
7.3.4 Market Forecast (2026-2034)
7.4 Chemotherapy
7.4.1 Overview
7.4.2 Historical and Current Market Trends (2020-2025)
7.4.3 Market Forecast (2026-2034)
7.5 Enteral Nutrition
7.5.1 Overview
7.5.2 Historical and Current Market Trends (2020-2025)
7.5.3 Market Forecast (2026-2034)
7.6 Parenteral Nutrition
7.6.1 Overview
7.6.2 Historical and Current Market Trends (2020-2025)
7.6.3 Market Forecast (2026-2034)
7.7 Specialty Pharmaceuticals
7.7.1 Overview
7.7.2 Historical and Current Market Trends (2020-2025)
7.7.3 Market Forecast (2026-2034)
7.8 Others
7.8.1 Historical and Current Market Trends (2020-2025)
7.8.2 Market Forecast (2026-2034)
8 SOUTH KOREA HOME INFUSION THERAPY MARKET – BREAKUP BY REGION
8.1 Seoul Capital Area
8.1.1 Overview
8.1.2 Historical and Current Market Trends (2020-2025)
8.1.3 Market Breakup by Product
8.1.4 Market Breakup by Application
8.1.5 Key Players
8.1.6 Market Forecast (2026-2034)
8.2 Yeongnam (Southeastern Region)
8.2.1 Overview
8.2.2 Historical and Current Market Trends (2020-2025)
8.2.3 Market Breakup by Product
8.2.4 Market Breakup by Application
8.2.5 Key Players
8.2.6 Market Forecast (2026-2034)
8.3 Honam (Southwestern Region)
8.3.1 Overview
8.3.2 Historical and Current Market Trends (2020-2025)
8.3.3 Market Breakup by Product
8.3.4 Market Breakup by Application
8.3.5 Key Players
8.3.6 Market Forecast (2026-2034)
8.4 Hoseo (Central Region)
8.4.1 Overview
8.4.2 Historical and Current Market Trends (2020-2025)
8.4.3 Market Breakup by Product
8.4.4 Market Breakup by Application
8.4.5 Key Players
8.4.6 Market Forecast (2026-2034)
8.5 Others
8.5.1 Historical and Current Market Trends (2020-2025)
8.5.2 Market Forecast (2026-2034)
9 SOUTH KOREA HOME INFUSION THERAPY MARKET – COMPETITIVE LANDSCAPE
9.1 Overview
9.2 Market Structure
9.3 Market Player Positioning
9.4 Top Winning Strategies
9.5 Competitive Dashboard
9.6 Company Evaluation Quadrant
10 PROFILES OF KEY PLAYERS
10.1 Company A
10.1.1 Business Overview
10.1.2 Products Offered
10.1.3 Business Strategies
10.1.4 SWOT Analysis
10.1.5 Major News and Events
10.2 Company B
10.2.1 Business Overview
10.2.2 Products Offered
10.2.3 Business Strategies
10.2.4 SWOT Analysis
10.2.5 Major News and Events
10.3 Company C
10.3.1 Business Overview
10.3.2 Products Offered
10.3.3 Business Strategies
10.3.4 SWOT Analysis
10.3.5 Major News and Events
10.4 Company D
10.4.1 Business Overview
10.4.2 Products Offered
10.4.3 Business Strategies
10.4.4 SWOT Analysis
10.4.5 Major News and Events
10.5 Company E
10.5.1 Business Overview
10.5.2 Products Offered
10.5.3 Business Strategies
10.5.4 SWOT Analysis
10.5.5 Major News and Events
11 SOUTH KOREA HOME INFUSION THERAPY MARKET - INDUSTRY ANALYSIS
11.1 Drivers, Restraints, and Opportunities
11.1.1 Overview
11.1.2 Drivers
11.1.3 Restraints
11.1.4 Opportunities
11.2 Porters Five Forces Analysis
11.2.1 Overview
11.2.2 Bargaining Power of Buyers
11.2.3 Bargaining Power of Suppliers
11.2.4 Degree of Competition
11.2.5 Threat of New Entrants
11.2.6 Threat of Substitutes
11.3 Value Chain Analysis
12 APPENDIX
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 SOUTH KOREA HOME INFUSION THERAPY MARKET - INTRODUCTION
4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence
5 SOUTH KOREA HOME INFUSION THERAPY MARKET LANDSCAPE
5.1 Historical and Current Market Trends (2020-2025)
5.2 Market Forecast (2026-2034)
6 SOUTH KOREA HOME INFUSION THERAPY MARKET - BREAKUP BY PRODUCT
6.1 Infusion Pumps
6.1.1 Overview
6.1.2 Historical and Current Market Trends (2020-2025)
6.1.3 Market Segmentation
6.1.3.1 Elastomeric
6.1.3.2 Electromechanical
6.1.3.3 Gravity
6.1.3.4 Others
6.1.4 Market Forecast (2026-2034)
6.2 Intravenous Sets
6.2.1 Overview
6.2.2 Historical and Current Market Trends (2020-2025)
6.2.3 Market Forecast (2026-2034)
6.3 IV Cannulas
6.3.1 Overview
6.3.2 Historical and Current Market Trends (2020-2025)
6.3.3 Market Forecast (2026-2034)
6.4 Needleless Connectors
6.4.1 Overview
6.4.2 Historical and Current Market Trends (2020-2025)
6.4.3 Market Forecast (2026-2034)
7 SOUTH KOREA HOME INFUSION THERAPY MARKET - BREAKUP BY APPLICATION
7.1 Anti-Infective
7.1.1 Overview
7.1.2 Historical and Current Market Trends (2020-2025)
7.1.3 Market Forecast (2026-2034)
7.2 Endocrinology
7.2.1 Overview
7.2.2 Historical and Current Market Trends (2020-2025)
7.2.3 Market Segmentation
7.2.3.1 Diabetes
7.2.3.2 Others
7.2.4 Market Forecast (2026-2034)
7.3 Hydration Therapy
7.3.1 Overview
7.3.2 Historical and Current Market Trends (2020-2025)
7.3.3 Market Segmentation
7.3.3.1 Athletes
7.3.3.2 Others
7.3.4 Market Forecast (2026-2034)
7.4 Chemotherapy
7.4.1 Overview
7.4.2 Historical and Current Market Trends (2020-2025)
7.4.3 Market Forecast (2026-2034)
7.5 Enteral Nutrition
7.5.1 Overview
7.5.2 Historical and Current Market Trends (2020-2025)
7.5.3 Market Forecast (2026-2034)
7.6 Parenteral Nutrition
7.6.1 Overview
7.6.2 Historical and Current Market Trends (2020-2025)
7.6.3 Market Forecast (2026-2034)
7.7 Specialty Pharmaceuticals
7.7.1 Overview
7.7.2 Historical and Current Market Trends (2020-2025)
7.7.3 Market Forecast (2026-2034)
7.8 Others
7.8.1 Historical and Current Market Trends (2020-2025)
7.8.2 Market Forecast (2026-2034)
8 SOUTH KOREA HOME INFUSION THERAPY MARKET – BREAKUP BY REGION
8.1 Seoul Capital Area
8.1.1 Overview
8.1.2 Historical and Current Market Trends (2020-2025)
8.1.3 Market Breakup by Product
8.1.4 Market Breakup by Application
8.1.5 Key Players
8.1.6 Market Forecast (2026-2034)
8.2 Yeongnam (Southeastern Region)
8.2.1 Overview
8.2.2 Historical and Current Market Trends (2020-2025)
8.2.3 Market Breakup by Product
8.2.4 Market Breakup by Application
8.2.5 Key Players
8.2.6 Market Forecast (2026-2034)
8.3 Honam (Southwestern Region)
8.3.1 Overview
8.3.2 Historical and Current Market Trends (2020-2025)
8.3.3 Market Breakup by Product
8.3.4 Market Breakup by Application
8.3.5 Key Players
8.3.6 Market Forecast (2026-2034)
8.4 Hoseo (Central Region)
8.4.1 Overview
8.4.2 Historical and Current Market Trends (2020-2025)
8.4.3 Market Breakup by Product
8.4.4 Market Breakup by Application
8.4.5 Key Players
8.4.6 Market Forecast (2026-2034)
8.5 Others
8.5.1 Historical and Current Market Trends (2020-2025)
8.5.2 Market Forecast (2026-2034)
9 SOUTH KOREA HOME INFUSION THERAPY MARKET – COMPETITIVE LANDSCAPE
9.1 Overview
9.2 Market Structure
9.3 Market Player Positioning
9.4 Top Winning Strategies
9.5 Competitive Dashboard
9.6 Company Evaluation Quadrant
10 PROFILES OF KEY PLAYERS
10.1 Company A
10.1.1 Business Overview
10.1.2 Products Offered
10.1.3 Business Strategies
10.1.4 SWOT Analysis
10.1.5 Major News and Events
10.2 Company B
10.2.1 Business Overview
10.2.2 Products Offered
10.2.3 Business Strategies
10.2.4 SWOT Analysis
10.2.5 Major News and Events
10.3 Company C
10.3.1 Business Overview
10.3.2 Products Offered
10.3.3 Business Strategies
10.3.4 SWOT Analysis
10.3.5 Major News and Events
10.4 Company D
10.4.1 Business Overview
10.4.2 Products Offered
10.4.3 Business Strategies
10.4.4 SWOT Analysis
10.4.5 Major News and Events
10.5 Company E
10.5.1 Business Overview
10.5.2 Products Offered
10.5.3 Business Strategies
10.5.4 SWOT Analysis
10.5.5 Major News and Events
11 SOUTH KOREA HOME INFUSION THERAPY MARKET - INDUSTRY ANALYSIS
11.1 Drivers, Restraints, and Opportunities
11.1.1 Overview
11.1.2 Drivers
11.1.3 Restraints
11.1.4 Opportunities
11.2 Porters Five Forces Analysis
11.2.1 Overview
11.2.2 Bargaining Power of Buyers
11.2.3 Bargaining Power of Suppliers
11.2.4 Degree of Competition
11.2.5 Threat of New Entrants
11.2.6 Threat of Substitutes
11.3 Value Chain Analysis
12 APPENDIX
